Study to help prevent stillbirth with new risk screening
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study is testing a new way to find out early in pregnancy if you might be at risk for stillbirth. If you join, researchers will follow you through delivery to see if the screening tool helps improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- This is your first pregnancy that has reached at least 20 weeks (no prior births after 20 weeks)
- You are pregnant with one baby (not twins or more)
- Your pregnancy is between 10 weeks and 17 weeks 6 days at your dating ultrasound
- You can give blood samples and are able to follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
This study looks at pregnancy results for women who had fertility treatments (like IVF). You can join if your baby is alive on ultrasound and you are between 11 and 14 weeks pregnant.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This study collects information from pregnant people with different risk levels to better understand and improve pregnancy care. It includes both those with known or suspected placenta issues and those with low-risk pregnancies.
This study uses special imaging techniques to look at the placenta during pregnancy. It aims to learn more about normal pregnancies and those where the baby is growing more slowly than expected.
This study tests a decision-support tool (a structured way to guide conversations) for parents facing a high risk of delivering very early (about 22–26 weeks). It may help you and your baby’s care team make clearer, more aligned choices about neonatal (newborn) treatment.
Hear when a new GDM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.